1. Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
    Wan Sun et al, 2017, The Journal of Clinical Pharmacology CrossRef
  2. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma–cyclin-dependent kinase activation
    Patricia Sanmartín-Salinas et al, 2018, Journal of Gastroenterology CrossRef
  3. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
    Jiayuan Wang et al, 2017, Journal of Translational Medicine CrossRef
  4. Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models
    Christin Riess et al, 2021, Cell Death Discovery CrossRef
  5. Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
    Oana-Maria Thoma et al, 2021, Frontiers in Pharmacology CrossRef
  6. Impact of Acid‐Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH‐Dependent Solubility, With Different Food Intake Conditions
    Wan Sun et al, 2017, Clinical Pharmacology in Drug Development CrossRef
  7. Quantitative Proteomics Reveals the Antitumor Effects of Sodium New Houttuyfonate on Non-small Cell Lung Cancer
    Xiao-Yan Yang et al, 2021, Journal of Exploratory Research in Pharmacology CrossRef
  8. CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1
    Anuja Sathe et al, 2016, Journal of Urology CrossRef
  9. Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
    Carmen Oi Ning Leung et al, 2023, Nature Communications CrossRef
  10. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma
    Yunfei Liao et al, 2016, Cancer and Metastasis Reviews CrossRef
  11. Targeting CDK6 in cancer: State of the art and new insights
    Solomon Tadesse et al, 2015, Cell Cycle CrossRef
  12. Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data
    Neelima Vidula et al, 2016, Clinical Breast Cancer CrossRef
  13. Trichostatin A preferentially reverses the upregulation of gene‐expression levels induced by gain of chromosome 7 in colorectal cancer cell lines
    Floryne O. Buishand et al, 2018, Genes, Chromosomes and Cancer CrossRef
  14. CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review
    Dragica Pavlovic et al, 2023, Therapeutic Advances in Medical Oncology CrossRef
  15. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype
    Gary L. Johanning et al, 2017, Scientific Reports CrossRef
  16. Synthesis, cytotoxic evaluation, and molecular docking studies of the semi-synthetic “triterpenoid-steroid” hybrids
    Irina A. Tolmacheva et al, 2018, Steroids CrossRef
  17. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer
    Archana Balakrishnan et al, 2016, World Journal of Gastroenterology CrossRef
  18. Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors
    Alsu Z. Malikova et al, 2021, International Journal of Molecular Sciences CrossRef
  19. Spontaneous Genomic Alterations in a Chimeric Model of Colorectal Cancer Enable Metastasis and Guide Effective Combinatorial Therapy
    Yinghui Zhou et al, 2014, PLoS ONE CrossRef
  20. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor
    Hani J Alturkmani et al, 2015, Expert Opinion on Investigational Drugs CrossRef
  21. The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma
    Jeffrey D Altenburg et al, 2015, Expert Opinion on Investigational Drugs CrossRef

  22. Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?


    Chu Wu et al, 2020, OncoTargets and Therapy CrossRef
  23. Cytotoxic Activity of Raphanus sativus Linn. on Selected Cancer Cell Lines and Mechanistic Pathways Predicted Through Mathematical Modeling
    Angelyn Lao et al, 2021, Modelling, Simulation and Applications of Complex Systems CrossRef